Ningbo University Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2013
NCT02647515
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

The Affiliated Hospital of Medical School, Ningbo University | The Affiliated Hospital of Medical School of Ningbo University | The affiliated people's hospital of Ningbo University | Yinzhou Hospital Affiliated to Medical School of Ningbo University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenomyosis (Phase 3)

Diabetic Retinopathy (Phase 4)

Glaucoma (Phase 4)

Glaucoma, Neovascular (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 15